OCUTERRA THERAPEUTICS
OcuTerra Therapeutics, Inc. is developing innovative drugs for ophthalmic diseases for which the current standard of care does not prevent or control the progression of the disease.
OCUTERRA THERAPEUTICS
Industry:
Biotechnology Therapeutics
Founded:
2011-01-01
Address:
Boston, Massachusetts, United States
Country:
United States
Website Url:
http://www.ocuterratx.com
Status:
Active
Contact:
(617) 701-7382
Email Addresses:
[email protected]
Total Funding:
35 M USD
Technology used in webpage:
Viewport Meta SPF SSL By Default Google Font API LetsEncrypt Content Delivery Network Euro Organization Schema GoDaddy DNS Typekit
Similar Organizations
Akebia Therapeutics
Akebia Therapeutics develops treatments for ischemia and vascular diseases.
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Semma Therapeutics
Semma Therapeutics was founded to develop transformative therapies for Type 1 diabetes patients.
Spero Therapeutics
Spero Therapeutics is developing first in class therapeutics for treatment of gram-negative infections.
Synspira
Synspira Therapeutics is focused on developing a rationally designed portfolio of products in cystic fibrosis and other rare diseases.
Tenaya Therapeutics
Tenaya Therapeutics is a developer of novel therapies designed to offer treatment for heart disease.
Current Employees Featured
Investors List
Robin Hood Ventures
Robin Hood Ventures investment in Series B - OcuTerra Therapeutics
Key Employee Changes
| Date | New article |
|---|---|
| 2022-04-04 | OcuTerra Appoints Majid Anderesi, MD, as Vice President of Clinical and Medical Affairs |
Official Site Inspections
http://www.ocuterratx.com Semrush global rank: 3.09 M Semrush visits lastest month: 5.19 K
- Host name: 198.185.159.145
- IP address: 198.185.159.145
- Location: New York United States
- Latitude: 40.7157
- Longitude: -74
- Metro Code: 501
- Timezone: America/New_York
- Postal: 10013
